Health Care — Hawley pushes to revoke approval of abortion pill

Presented by Alliance for Aging Research

View Online Health Care Health Care   PRESENTED BY  The Big Story  Hawley's push to revoke abortion pill approval picks up steam Sen. Josh Hawley (R-Mo.) has picked up three Republican allies in his endeavor to revoke approval of the abortion pill mifepristone.  © Greg Nash Earlier this month, Hawley introduced a bill titled the "Safeguarding Women from Chemical Abortion Act" that would ban the sale of mifepristone for use in abortions while still allowing it to be prescribed to treat Cushing's syndrome, a rare disorder associated with high cortisol levels for prolonged periods of time.   GOP Sens. John Cornyn (Texas), Ted Budd (N.C.) and Marsha Blackburn (Tenn.) have since put their support behind the bill.   Hawley urged Republican senators to support the bill in a "Dear Colleague," warning that if Congress fails to act, "mifepristone will continue to expose increasing numbers of American women to severe risks."    He said that the Obama and Biden administration stripped away safety guidelines that the FDA put in place when the drug was first approved under the Clinton administration in 2000.    The FDA approved a second generic mifepristone pill in October, making it more accessible.    "Mifepristone can now be shipped through the mail with the click of a button. Today the drug accounts for 70 percent of abortions in the United States, and at least 7.5 million women in the country have taken it since it was approved in 2000," Hawley wrote in his letter, adding that the widespread availability of mifepristone has undermined the Supreme Court's 2022 decision to overturn Roe v. Wade, the landmark 1973 case establishing the nationwide right to an abortion.    Read more from The Hill's Alex Bolton.  Welcome to The Hill's Health Care newsletter, I'm Joseph Choi — every week we follow the latest moves on how Washington impacts your health. Did someone forward you this newsletter? Subscribe here. Essential Reads  How policy will be impacting the health care sector this week and beyond: Hawley bill to end FDA approval mifepristone picks up Senate GOP support Sen. Josh Hawley's (R-Mo.) bill to revoke the Food and Drug Administration's (FDA) approval of the drug mifepristone for use in terminating pregnancies is picking up Senate Republican support, as the push to stop its shipment across state lines is becoming a top priority of the anti-abortion movement.   Hawley's bill, which would make distributing and labeling mifepristone for abortions a violation of the Food, Drug and …  Full Story Senate deal reached to cap insulin costs A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients on private insurance. Sens. Jeanne Shaheen (D-N.H.), Susan Collins (R-Maine), Raphael Warnock (D-Ga.) and John Kennedy (R-La.) introduced the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, which would limit out-of-pocket costs for people with diabetes by waiving any deductibles …  Full Story Fewer people traveled for abortions as telehealth went up: report A new report from the reproductive health nonprofit The Guttmacher Institute found that fewer people are traveling from states with total abortion bans to access abortion services, while the rate of telehealth use for at-home abortions has gone up. In the years following the 2022 Dobbs decision by the Supreme Court, overturning Roe v. Wade, travel across state lines for abortions has gone down. In 2023, about 170,000 people …  Full Story A MESSAGE FROM ALLIANCE FOR AGING RESEARCH   In Other News  Branch out with a different read from The Hill: Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine. Details of the agreement, which was finalized in federal … Full Story Around the Nation  Local and state headlines on health care: 6 providers at MaineHealth will serve on national 'street medicine' council (Maine Public)  Medicare billing snafu brings new financial woes to Minnesota rural hospitals (MPR News)  How outlawing flavored tobacco saved Massachusetts $70 million in health care costs (WGBH)  What We're Reading  Health news we've flagged from other outlets: Bhattacharya addresses CDC director role, works to bolster staff morale in first all-hands meeting (Stat)  Doctors worry about FDA scrutiny of RSV shots to protect babies (NPR)  UK meningitis outbreak may worsen, health security agency warns (Bloomberg)  What People Think  Opinions related to health submitted to The Hill: Price tags for patients: I'm still fighting for honest health care transparency Children on the transplant wait list are dying — Congress can save them    You're all caught up. See you tomorrow!  Check out The Hill's Health Care page for the latest coverage. Like this newsletter? Take a moment to view our other topical products here 📩 Privacy Policy  |  Manage Subscriptions  |  Unsubscribe  400 N Capitol Street NW Suite 650, Washington, DC 20001 Copyright © 1998 - 2026 Nexstar Media Inc. | All Rights Reserved.

If you believe this has been sent to you in error, please safely unsubscribe.